Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1223 clinical trials
featured
Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

  • 158 views
  • 08 Nov, 2020
  • 1 location
featured
Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

  • 140 views
  • 08 Nov, 2020
  • 1 location
featured
Advanced Stage Non-small Cell Lung Cancer

Advanced Stage Non-small Cell Lung Cancer

  • 200 views
  • 08 Nov, 2020
  • 1 location
featured
Advanced Non-Small Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer

  • 128 views
  • 08 Nov, 2020
  • 1 location
featured
Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET

  • 342 views
  • 08 Nov, 2020
  • 38 locations
featured
Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer

Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer

  • 356 views
  • 08 Nov, 2020
  • 2 locations
featured
An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

adjuvant chemotherapy
KIT
lung cancer
lung carcinoma
osimertinib
  • 358 views
  • 08 Dec, 2020
  • 4 locations
featured
A Randomized, Double Blind, Phase 3 Study of Platinum-Based Chemotherapy With or Without INCMGA00012 in First-Line Metastatic Squamous and Nonsquamous Non–Small Cell Lung Cancer.

The purpose of this study is to assess the efficacy and safety of platinum-based chemotherapy with or without INCMGA00012 in participants with metastatic squamous and nonsquamous non–small cell lung cancer (NSCLC).

lung cancer
measurable disease
cancer chemotherapy
platinum-based chemotherapy
lung carcinoma
  • 12 views
  • 14 Dec, 2020
  • 1 location
featured
Phase 3 Study of MRTX849 vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-12)

This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 versus docetaxel in patients who have been previously treated for metastatic NSCLC with a KRAS G12C mutation.

metastatic non-small cell lung cancer
recurrent non-small cell lung cancer
lung cancer
lung metastases
refractory non-small cell lung cancer
  • 0 views
  • 07 May, 2021
  • 17 locations
featured
Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation (KRYSTAL-7)

This Phase 2 study evaluates the clinical activity and safety of MRTX849 in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS.

  • 0 views
  • 30 Apr, 2021
  • 23 locations